Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
DexCom, Inc. | DXCM | 50.76K | $3.42M |
Roivant Sciences Ltd. | ROIV | 61.1K | $2.16M |
Trevi Therapeutics, Inc. | TRVI | 65.6K | $1.22M |
Tectonic Therapeutic, Inc. | TECX | 71.01K | $2.44M |
Kura Oncology, Inc. | KURA | 71.48K | $784.14K |
Definium Therapeutics, Inc. | DFTX | 78.31K | $3.68M |
ArriVent BioPharma, Inc. | AVBP | 79.04K | $2.75M |
Arcus Biosciences, Inc. | RCUS | 110.87K | $3.42M |
Ardelyx, Inc. | ARDX | 122.39K | $624.21K |
Alphatec Holdings, Inc. | ATEC | 185.9K | $1.61M |
Summit Therapeutics Inc. | SMMT | 220.18K | $3.21M |